9 Oct 2020 16:05
Mereo BioPharma Group plc
Director and PDMR Dealings
Â
London and Redwood City, Calif., October 9, 2020 - Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or "the Company", a clinical-stage biopharmaceutical company focused on oncology and rare diseases, received notification that on October 7 2020 Denise Scots-Knight, Chief Executive Officer of Mereo, purchased 12,711 American Depositary Shares (ADSs) at a price of USD 2.36 per ADS, Brian Schwartz, Non-Executive Director of Mereo, purchased 20,000 ADSs at a price of USD 2.35 per ADS and John Richard, Head of Corporate Development of Mereo, purchased 6,500 ADSs at a price of USD 2.36 per ADS.
Â
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.
Â
1 | Details of the person discharging managerial responsibilities | |||||
a) | Name | Denise Scots-Knight | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mereo BioPharma Group plc | ||||
b) | LEI | 213800U8JQHIJOS5AS09 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs) Â | ||||
b) | Nature of the transaction | PURCHASE | ||||
c) | Price(s) and volume(s) | Â
  | ||||
d) | Aggregated information: volume, Price | 30043.72 | ||||
e) | Date of the transaction | 2020-10-07 | ||||
f) | Place of the transaction | XNMS |
Â
1 | Details of the person discharging managerial responsibilities | |||||
a) | Name | Brian Schwartz | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-Executive Director | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mereo BioPharma Group plc | ||||
b) | LEI | 213800U8JQHIJOS5AS09 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs) Â | ||||
b) | Nature of the transaction | PURCHASE | ||||
c) | Price(s) and volume(s) | Â
  | ||||
d) | Aggregated information: volume, Price | 47068.00 | ||||
e) | Date of the transaction | 2020-10-07 | ||||
f) | Place of the transaction | XNMS |
Â
Â
1 | Details of the person discharging managerial responsibilities | |||||
a) | Name | John Richard | ||||
2 | Reason for the notification | |||||
a) | Position/status | Head of Corporate Development | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mereo BioPharma Group plc | ||||
b) | LEI | 213800U8JQHIJOS5AS09 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY SHARES (ADSs) Â | ||||
b) | Nature of the transaction | PURCHASE | ||||
c) | Price(s) and volume(s) | Â
  | ||||
d) | Aggregated information: volume, Price | 15330.06 | ||||
e) | Date of the transaction | 2020-10-07 | ||||
f) | Place of the transaction | XNMS |
Â